Eppin Pharma Awarded a Small Business Research Loan for $250,000 from the NCBC
Eppin Pharma of Chapel Hill is pleased to announce that it was one of two companies to receive a Small Business Research Loan for $250,000 from the North Carolina Biotech Center to advance the development of its orally delivered, safe, reversible, non-hormonal male contraceptive. Funds will be utilized to optimize bioavailability and assess the safety and efficacy of the company’s lead compounds in preparation for an IND application anticipated in 2018/2019
July 21, 2016
Read more at http://wraltechwire.com/nc-biotech-center-awarded-2-5m-to-universities-and-companies/15866728/?utm_medium=email&utm_campaign=newsletter&utm_source=wraltechwire#2Ty3POvRpWR4HcQD.99
About Eppin Pharma
Eppin Pharma Inc. of Chapel Hill, North Carolina, is an emerging pharmaceutical company focused on developing a safe, non-hormonal male contraceptive taken orally. The company was founded based upon technology licensed from the University of North Carolina at Chapel Hill and has received support from the University of North Carolina at Chapel Hill’s Carolina KickStart Commercialization program (North Carolina Translational and Clinical Sciences Institute).
Research support referred to in this press release will be supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under Award Number R41HD084007. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Eppin Pharma Inc www.eppinpharma.com
Michael O’Rand PhD, CEO & President email@example.com
Jeffrey Handler PhD, COO firstname.lastname@example.org